Functional diversity of SDF-1 splicing variants

Miroslaw Janowski

Research output: Contribution to journalArticle

Abstract

SDF-1 is ubiquitously expressed in vertebrate tissues in a constitutive manner. It performs an essential role in cell migration and proliferation as well as participates in tissue-specific physiological processes such as neuromodulation. It is also involved in many pathological processes including: HIV infection, metastatic malignancy, chronic inflammatory disorders and benign proliferative diseases. SDF-1 is mostly regulated at the splicing, and not transcriptional level. Different splicing variants share agonist potency to their cognate receptor, CXCR4, but are characterized by distinct properties. SDF-1α is the predominant isoform found in all organs, but undergoes rapid proteolysis in blood. SDF-1β is more resistant to blood-dependent degradation, stimulates angiogenesis and is present in highly vascularized organs such as: the liver, spleen and kidneys. In contrast, SDF-1γ is located in very active, less vascularized organs susceptible to infarction such as the heart and the brain. The understanding of the functional diversity of the different splicing variants will help in developing therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)243-249
Number of pages7
JournalCell Adhesion and Migration
Volume3
Issue number3
StatePublished - Jul 2009
Externally publishedYes

Fingerprint

Physiological Phenomena
CXCR4 Receptors
Pathologic Processes
Infarction
Proteolysis
HIV Infections
Cell Movement
Vertebrates
Protein Isoforms
Spleen
Cell Proliferation
Kidney
Liver
Brain
Neoplasms
Therapeutics

Keywords

  • Cell based-therapy
  • CXCR4
  • CXCR7
  • Isoform
  • SDF-1
  • Splicing variant

ASJC Scopus subject areas

  • Cell Biology
  • Cellular and Molecular Neuroscience

Cite this

Functional diversity of SDF-1 splicing variants. / Janowski, Miroslaw.

In: Cell Adhesion and Migration, Vol. 3, No. 3, 07.2009, p. 243-249.

Research output: Contribution to journalArticle

Janowski, M 2009, 'Functional diversity of SDF-1 splicing variants', Cell Adhesion and Migration, vol. 3, no. 3, pp. 243-249.
Janowski, Miroslaw. / Functional diversity of SDF-1 splicing variants. In: Cell Adhesion and Migration. 2009 ; Vol. 3, No. 3. pp. 243-249.
@article{5e4493b5a50e48e1b49ab8a70df3b509,
title = "Functional diversity of SDF-1 splicing variants",
abstract = "SDF-1 is ubiquitously expressed in vertebrate tissues in a constitutive manner. It performs an essential role in cell migration and proliferation as well as participates in tissue-specific physiological processes such as neuromodulation. It is also involved in many pathological processes including: HIV infection, metastatic malignancy, chronic inflammatory disorders and benign proliferative diseases. SDF-1 is mostly regulated at the splicing, and not transcriptional level. Different splicing variants share agonist potency to their cognate receptor, CXCR4, but are characterized by distinct properties. SDF-1α is the predominant isoform found in all organs, but undergoes rapid proteolysis in blood. SDF-1β is more resistant to blood-dependent degradation, stimulates angiogenesis and is present in highly vascularized organs such as: the liver, spleen and kidneys. In contrast, SDF-1γ is located in very active, less vascularized organs susceptible to infarction such as the heart and the brain. The understanding of the functional diversity of the different splicing variants will help in developing therapeutic strategies.",
keywords = "Cell based-therapy, CXCR4, CXCR7, Isoform, SDF-1, Splicing variant",
author = "Miroslaw Janowski",
year = "2009",
month = "7",
language = "English (US)",
volume = "3",
pages = "243--249",
journal = "Cell Adhesion and Migration",
issn = "1933-6918",
publisher = "Landes Bioscience",
number = "3",

}

TY - JOUR

T1 - Functional diversity of SDF-1 splicing variants

AU - Janowski, Miroslaw

PY - 2009/7

Y1 - 2009/7

N2 - SDF-1 is ubiquitously expressed in vertebrate tissues in a constitutive manner. It performs an essential role in cell migration and proliferation as well as participates in tissue-specific physiological processes such as neuromodulation. It is also involved in many pathological processes including: HIV infection, metastatic malignancy, chronic inflammatory disorders and benign proliferative diseases. SDF-1 is mostly regulated at the splicing, and not transcriptional level. Different splicing variants share agonist potency to their cognate receptor, CXCR4, but are characterized by distinct properties. SDF-1α is the predominant isoform found in all organs, but undergoes rapid proteolysis in blood. SDF-1β is more resistant to blood-dependent degradation, stimulates angiogenesis and is present in highly vascularized organs such as: the liver, spleen and kidneys. In contrast, SDF-1γ is located in very active, less vascularized organs susceptible to infarction such as the heart and the brain. The understanding of the functional diversity of the different splicing variants will help in developing therapeutic strategies.

AB - SDF-1 is ubiquitously expressed in vertebrate tissues in a constitutive manner. It performs an essential role in cell migration and proliferation as well as participates in tissue-specific physiological processes such as neuromodulation. It is also involved in many pathological processes including: HIV infection, metastatic malignancy, chronic inflammatory disorders and benign proliferative diseases. SDF-1 is mostly regulated at the splicing, and not transcriptional level. Different splicing variants share agonist potency to their cognate receptor, CXCR4, but are characterized by distinct properties. SDF-1α is the predominant isoform found in all organs, but undergoes rapid proteolysis in blood. SDF-1β is more resistant to blood-dependent degradation, stimulates angiogenesis and is present in highly vascularized organs such as: the liver, spleen and kidneys. In contrast, SDF-1γ is located in very active, less vascularized organs susceptible to infarction such as the heart and the brain. The understanding of the functional diversity of the different splicing variants will help in developing therapeutic strategies.

KW - Cell based-therapy

KW - CXCR4

KW - CXCR7

KW - Isoform

KW - SDF-1

KW - Splicing variant

UR - http://www.scopus.com/inward/record.url?scp=68249122188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249122188&partnerID=8YFLogxK

M3 - Article

C2 - 19287206

AN - SCOPUS:68249122188

VL - 3

SP - 243

EP - 249

JO - Cell Adhesion and Migration

JF - Cell Adhesion and Migration

SN - 1933-6918

IS - 3

ER -